ArticleGeriatrics & gerontology international2025

Patient With Mild Alzheimer's Disease Homozygous for ApoE ε4 Showing Improved Cognition, No Brain Volume Loss, and Complete Amyloid Clearance After Lecanemab Treatment.

Haruo Hanyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.